Abstract
In 1987, collection of efficacy and safety information of children on Growth Hormone (GH) treatment started within KIGS. Today, 8887 patients are enrolled from 28 countries. Parental, perinatal and pretreatment information are given for the major groups in the Table. During this 5 year period, the age at start of treatment has been maintained except for the reduction from 9.7 to 5.0 years in the congenital GHD children. The height at start of treatment has increased for all groups with an average of 0.4 SDS. The male dominance has been kept and the parental height has been below average for all patients but those with malignancies. This KIGS database will continue to provide us with important information about children on GH treatment in order to achieve earlier diagnoses, more optimal treatment for different etiology groups as well as collecting safety information.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albensson-Wikland, K., Wilton, P., Wallström, A. et al. DEMOGRAPHY OF CHILDREN ON GROWTH HORMONE (GH) TREATMENT ENROLLED 1987–1992 IN KIGS Kabi Pharmacia International Growth Study. Pediatr Res 33 (Suppl 5), S53 (1993). https://doi.org/10.1203/00006450-199305001-00300
Issue Date:
DOI: https://doi.org/10.1203/00006450-199305001-00300